📣 VC round data is live. Check it out!
- Public Comps
- JD Health
JD Health Valuation Multiples
Discover JD Health's revenue and EBITDA valuation multiples and investment history, alongside public comparables like LY Corporation, BrightSpring Health, Dr. Sulaiman Al Habib, Rakuten and more.
JD Health Overview
About JD Health
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
Founded
2018
HQ

Employees
3.6K
Website
Financials (LTM)
EV
$9B
Valuation Multiples
Start free trialJD Health Financials
JD Health reported last 12-month revenue of $12B and EBITDA of $746M.
In the same LTM period, JD Health generated $3B in gross profit, $746M in EBITDA, and $827M in net income.
Revenue (LTM)
JD Health P&L
In the most recent fiscal year, JD Health reported revenue of $11B and EBITDA of $934M.
JD Health is profitable as of last fiscal year, with gross margin of 25%, EBITDA margin of 9%, and net margin of 7%.
Financial data powered by Morningstar, Inc.
JD Health Stock Performance
JD Health has current market cap of $16B, and enterprise value of $9B.
Market Cap Evolution
JD Health's stock price is $4.99.
JD Health share price increased by 1.9% in the last 30 days, and decreased by 9.0% in the last year.
JD Health has an EPS (earnings per share) of $0.25.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $9B | $16B | 1.9% | 1.9% | -16.9% | -9.0% | $0.25 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialJD Health Valuation Multiples
JD Health trades at 0.8x EV/Revenue multiple, and 12.0x EV/EBITDA.
EV / Revenue (LTM)
JD Health Financial Valuation Multiples
As of June 2, 2026, JD Health has market cap of $16B and EV of $9B.
JD Health has a P/E ratio of 19.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified JD Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


JD Health Margins & Growth Rates
JD Health grew revenue by 18% but EBITDA decreased by 12% in the last fiscal year.
In the most recent fiscal year, JD Health reported gross margin of 25%, EBITDA margin of 9%, and net margin of 7%.
JD Health Margins
JD Health Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
JD Health Operational KPIs
JD Health's revenue per employee in the last FY averaged $3.0M, while opex per employee averaged $0.6M for the same period.
JD Health's Rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
JD Health's Rule of X is 51% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
JD Health Competitors
JD Health competitors include LY Corporation, BrightSpring Health, Dr. Sulaiman Al Habib, Rakuten, Wayfair, Lenskart, Chewy, Meesho, Nykaa and Sigma Healthcare.
Most JD Health public comparables operate across Consumer E-commerce, Pharmacies, Vertical E-commerce and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.0x | 1.8x | 8.8x | 7.4x | |||
| 1.0x | 1.0x | 21.8x | 19.2x | |||
| 6.1x | 5.8x | 23.6x | 24.0x | |||
| 0.9x | 0.9x | 5.0x | 4.7x | |||
| 1.0x | 1.0x | 16.4x | 15.6x | |||
| 10.0x | 9.5x | 46.6x | 47.1x | |||
| 0.7x | 0.7x | 12.2x | 11.1x | |||
| 6.1x | 5.8x | (67.2x) | (60.4x) | |||
This data is available for Pro users. Sign up to see all JD Health competitors and their valuation data. Start Free Trial | ||||||
JD Health VC Funding History
Before going public, JD Health raised $2B in total equity funding, across 2 rounds.
Last private valuation of JD Health was $7B, after raising $1B in May 2019 from BPEA EQT, CICC, CPE, and 2 other investors.
JD Health Funding Rounds
Investments by JD Health
JD Health has invested in 1 company to date.
Latest investment by JD Health was on August 4th 2021. JD Health invested in Jiangxi Rimag Group in their $93M Series D round (EV/Revenue multiple available to Pro users).
Latest Investments by JD Health
| Description | Jiangxi Rimag Group Co Ltd is a medical group specializing in medical imaging in China. the company generates revenue mainly through the following medical imaging services and solutions: Imaging Center Services, Imaging Solution Services, and Rimag Cloud Services. The Imaging Center Services include examination and diagnostic services to patients and other healthcare consumers via its flagship imaging centers, such as MRI, CT, PET, X-ray, ultrasound and mammography. Majority of the revenue comes from Imaging center services. |
| HQ Country | |
| HQ City | Beijing |
| Deal Date | 4 Aug 2021 |
| Round | Series D |
| Raised | $93M |
| Investors | JD Health; Neovision Capital; OrbiMed; Tiefa Capital; Tongfu Fund |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all JD Health investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout JD Health
| When was JD Health founded? | JD Health was founded in 2018. |
| Where is JD Health headquartered? | JD Health is headquartered in China. |
| How many employees does JD Health have? | As of today, JD Health has over 3K employees. |
| Who is the CEO of JD Health? | JD Health's CEO is Enlin Jin. |
| Is JD Health publicly listed? | Yes, JD Health is a public company listed on HKEX. |
| What is the stock symbol of JD Health? | JD Health trades under 06618 ticker. |
| When did JD Health go public? | JD Health went public in 2020. |
| Who are competitors of JD Health? | JD Health main competitors include LY Corporation, BrightSpring Health, Dr. Sulaiman Al Habib, Rakuten, Wayfair, Lenskart, Chewy, Meesho, Nykaa, Sigma Healthcare. |
| What is the current market cap of JD Health? | JD Health's current market cap is $16B. |
| What is the current revenue of JD Health? | JD Health's last 12 months revenue is $12B. |
| What is the current revenue growth of JD Health? | JD Health revenue growth (NTM/LTM) is 18%. |
| What is the current EV/Revenue multiple of JD Health? | Current revenue multiple of JD Health is 0.8x. |
| What is the current EBITDA of JD Health? | JD Health's last 12 months EBITDA is $746M. |
| What is JD Health's EBITDA margin? | JD Health's last 12 months EBITDA margin is 6%. |
| What is the current EV/EBITDA multiple of JD Health? | Current EBITDA multiple of JD Health is 12.0x. |
| What is the current FCF of JD Health? | JD Health's last 12 months FCF is $1B. |
| What is JD Health's FCF margin? | JD Health's last 12 months FCF margin is 12%. |
| What is the current EV/FCF multiple of JD Health? | Current FCF multiple of JD Health is 6.3x. |
| How many companies JD Health has acquired to date? | JD Health hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies JD Health has invested to date? | As of June 2026, JD Health has invested in 1 company. |
| What was the last JD Health investment? | On 4th August 2021 JD Health invested in Jiangxi Rimag Group, participating in a $93M Series D round, alongside Neovision Capital, OrbiMed, Tiefa Capital, and Tongfu Fund. |
| In what companies JD Health invested in? | JD Health invested in Jiangxi Rimag Group. |
See public comps similar to JD Health
Lists including JD Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
